Trial NCT01464788

View at ClinicalTrials.gov 
Org. Study IDs: HSC-MS-11-0464

Last trial update was posted on 2017-05-11

MeSH Interventions

Argatroban Tissue Plasminogen Activator

MeSH Conditions

Ischemic Stroke Stroke

Other Conditions


Stopping Reasons

The study was halted prematurely at 90 of 105 planned patients due to the beneficial results of embolectomy clinical trials.

Limitations And Caveats

Study limitations include the open-label design that was necessary due to prohibitive costs of placebo manufacture and sham aPTT tests. Given that vessel imaging was not mandatory, a meaningful analysis of early recanalization rates was not possible.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID